Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease
Elīna Millere(Children's Clinical University Hospital), Viktorija Ķēniņa(Riga East University Hospital), Dmitrijs Rots(Radboud University Nijmegen), Kaj Blennow(Sahlgrenska University Hospital), Nataļja Kurjāne(Pauls Stradiņš Clinical University Hospital), Linda Gailīte(Pauls Stradiņš Clinical University Hospital), Nicholas J. Ashton(King's College London), Viktorija Priedīte, Einārs Kupats(Riga East University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Ieva Mičule(Children's Clinical University Hospital), Joel Simrén(University of Gothenburg)
Cited by 53
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k